Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.65 % |
3 Month Return | -5.99 % |
1 Year Return | + 2.3 % |
Market Stats | |
Previous Close | ₹393.10 |
Open | ₹393.60 |
Volume | 79.19K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,084.89Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹1,084.89 Cr |
P/B Ratio | 2.9 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | -12.23 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,084.89 Cr | 1.66% | 0.79 | NA | NA | |
NA | ₹64.17 Cr | 258.28% | 0.50 | NA | NA | |
NA | ₹123.98 Cr | 53.7% | 0.69 | NA | NA | |
NA | ₹94.27 Cr | 188.71% | 0.51 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr |
Organisation | Bajaj Healthcare Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Bajaj Healthcare Ltd
Bajaj Healthcare reported a significant turnaround in Q2 FY25, with a net profit of Rs 94.64 crore, up from a loss of Rs 34.60 crore YoY. Revenue surged 31.5% to Rs 133.08 crore, driven by strong performance across all segments, particularly opium processing, which grew 582.9%. The company has also made substantial debt repayments, enhancing its financial position.
Bajaj Healthcare Faces GST Demand and Plans Appeal - 30 Oct, 2024
Bajaj Healthcare Limited has received an ₹18.49 Crore GST demand over an ITC refund dispute. The company plans to appeal, asserting eligibility for a ₹17.41 Crore refund.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, BAJAJHCARE stock has moved up by 3.7%
Retail Holding Up
Retail Investor have increased holdings from 32.26% to 37.78% in Sep 2024 quarter
MF Holding Up
Mutual Funds have increased holdings from 0.00% to 1.31% in Sep 2024 quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.01% to 1.07% in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 56.3%
Promoter Holding Down
Promoters have decreased holdings from 67.73% to 59.19% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 59.19% | ||
Foreign Institutions | 1.07% | 18966.07 | |
Mutual Funds | 1.31% | 262200.00 | |
Retail Investors | 37.78% | 17.11 | |
Others | 0.66% | 36327.78 |
Bajaj Healthcare Ltd’s net profit jumped 373.41% since last year same period to ₹9.46Cr in the Q2 2024-2025. On a quarterly growth basis, Bajaj Healthcare Ltd has generated 32.68% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Bajaj Healthcare Ltd has declared dividend of ₹1 - translating a dividend yield of 0.51%.
Read More about DividendsBearish
Neutral
Bullish
Bajaj Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Bajaj Healthcare Ltd (BAJAJHCARE) share price today is ₹384.25
Bajaj Healthcare Ltd is listed on NSE
Bajaj Healthcare Ltd is listed on BSE
Today’s traded volume of Bajaj Healthcare Ltd(BAJAJHCARE) is 79.19K.
Today’s market capitalisation of Bajaj Healthcare Ltd(BAJAJHCARE) is ₹1084.89Cr.
Bajaj Healthcare Ltd(BAJAJHCARE | Price |
---|---|
52 Week High | ₹428.5 |
52 Week Low | ₹263.3 |
Bajaj Healthcare Ltd(BAJAJHCARE) share price is ₹384.25. It is down -10.33% from its 52 Week High price of ₹428.5
Bajaj Healthcare Ltd(BAJAJHCARE) share price is ₹384.25. It is up 45.94% from its 52 Week Low price of ₹263.3
Bajaj Healthcare Ltd(BAJAJHCARE | Returns |
---|---|
1 Day Returns | -8.85% |
1 Month Returns | 3.65% |
3 Month Returns | -5.99% |
1 Year Returns | 2.3% |